In a mouse xenograft model using HT-29 colon cancer cells, KSS19 as a single agent (25 mg/kg) was able to inhibit the tumor growth markedly along with a reduction of intratumoral COX-2 levels. The gene discussed is PTGS2; the disease is neoplasm.